Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer
Open Access
- 28 May 2026
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 56, 104203
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health and Care Research
This publication has 35 references indexed in Scilit:
- The POINTER-PC Study-determining Optimal Radiotherapy for Pelvic Nodal Recurrence in Prostate CancerClinical Oncology, 2025
- Carbon Ion Radiotherapy Reirradiation for Recurrent Malignancy: A Systematic AssessmentClinical Oncology, 2025
- Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled TrialsClinical Oncology, 2023
- Prospective randomized clinical studies involving reirradiation: update of a systematic reviewStrahlentherapie und Onkologie, 2023
- Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is RecruitingClinical Oncology, 2023
- Launch of the UK SABR Consortium Pelvic Stereotactic Ablative Radiotherapy Re-irradiation Guidelines and National AuditClinical Oncology, 2022
- A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam TherapyClinical Oncology, 2022
- The Special Medical Physics Consult Process for Reirradiation PatientsAdvances in Radiation Oncology, 2019
- Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysisJournal of Neuro-Oncology, 2018
- Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancerAdvances in Radiation Oncology, 2017